"Albuminuria" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
Descriptor ID |
D000419
|
MeSH Number(s) |
C12.777.934.734.269 C13.351.968.934.734.269 C23.888.942.750.269
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Albuminuria".
Below are MeSH descriptors whose meaning is more specific than "Albuminuria".
This graph shows the total number of publications written about "Albuminuria" by people in this website by year, and whether "Albuminuria" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 1 | 1 | 2 |
2004 | 1 | 3 | 4 |
2005 | 0 | 3 | 3 |
2006 | 3 | 3 | 6 |
2007 | 1 | 3 | 4 |
2008 | 2 | 3 | 5 |
2009 | 0 | 1 | 1 |
2010 | 4 | 3 | 7 |
2011 | 6 | 2 | 8 |
2012 | 2 | 3 | 5 |
2013 | 1 | 5 | 6 |
2014 | 4 | 4 | 8 |
2015 | 2 | 1 | 3 |
2016 | 3 | 3 | 6 |
2017 | 2 | 4 | 6 |
2018 | 2 | 0 | 2 |
2019 | 3 | 3 | 6 |
2020 | 1 | 3 | 4 |
2021 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
2023 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Albuminuria" by people in Profiles.
-
Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes. FASEB J. 2023 10; 37(10):e23175.
-
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus. Front Immunol. 2023; 14:1217121.
-
Trajectories of eGFR and risk of albuminuria in youth with type 2 diabetes: results from the TODAY cohort study. Pediatr Nephrol. 2023 12; 38(12):4137-4144.
-
Candidate biomarkers as predictors of future kidney disease and cardiovascular dysfunction in adolescents with type 2 diabetes. Diabetes Res Clin Pract. 2023 May; 199:110671.
-
Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population. Clin J Am Soc Nephrol. 2023 02 01; 18(2):204-212.
-
Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2022 Nov; 11(21):e026762.
-
Prevalence and Risk Factors for Kidney Disease and Elevated BP in 2-Year-Old Children Born Extremely Premature. Clin J Am Soc Nephrol. 2022 08; 17(8):1129-1138.
-
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis. Clin J Am Soc Nephrol. 2021 03 08; 16(3):384-395.
-
Nomenclature for kidney function and disease-executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Eur Heart J. 2020 12 21; 41(48):4592-4598.
-
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program. Am J Kidney Dis. 2021 01; 77(1):23-34.e1.